Genetic Technology Alert. Genetic Test Patented for Effective Weight Management; Gene Therapy for Muscular Dystrophy; Next Generation Sequencing Tests for Colorectal Cancer

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles genetic test patented for effective weight management, gene therapy for muscular dystrophy, and next generation sequencing tests for colorectal cancer.

Table of Contents

Genetic Technology Alert. Genetic Test Patented for Effective Weight Management; Gene Therapy for Muscular Dystrophy; Next Generation Sequencing Tests for Colorectal CancerIn This Issue1. GENETIC TEST PATENTED FOR EFFECTIVE WEIGHT MANAGEMENT2. GENE THERAPY FOR MUSCULAR DYSTROPHY3. NEXT GENERATION SEQUENCING TESTS FOR COLORECTAL CANCER4. GLOBAL PATENTS RELATED TO CYSTIC FIBROSIS




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.